ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Greenwald Reorganizing DCPC, Elevates Surveillance to Program, Moves Branches

February 3, 1989

AIDS Commission Asks, “Give Us A Chance”

September 18, 1987

“Long Overdue” Efforts By States Urged To Help Fund Community, Regional Cancer Control Efforts

August 4, 1978

Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.

December 14, 2001

Cooperative Group Chairmen Told They Must Do Their Own Planning, Will Get Funds Increase

September 26, 1975

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983